Zoetis Inc. (NYSE:ZTS) Position Reduced by Ameritas Advisory Services LLC

Posted by Defense World Staff on Jul 23rd, 2023

Ameritas Advisory Services LLC lowered its stake in Zoetis Inc. (NYSE:ZTS – Free Report) by 30.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 2,037 shares of the company’s stock after selling 878 shares during the period. Ameritas Advisory Services LLC’s holdings in Zoetis were worth $358,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of ZTS. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its stake in Zoetis by 430.8% during the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 138 shares of the company’s stock valued at $26,000 after buying an additional 112 shares in the last quarter. Worth Asset Management LLC acquired a new stake in shares of Zoetis during the 1st quarter valued at approximately $26,000. IAG Wealth Partners LLC bought a new position in Zoetis during the fourth quarter worth $29,000. Elequin Securities LLC acquired a new position in Zoetis in the fourth quarter worth $32,000. Finally, J.Safra Asset Management Corp increased its stake in Zoetis by 78.8% during the fourth quarter. J.Safra Asset Management Corp now owns 295 shares of the company’s stock valued at $43,000 after purchasing an additional 130 shares during the last quarter. Institutional investors and hedge funds own 98.18% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on ZTS shares. Piper Sandler reduced their price target on shares of Zoetis from $220.00 to $210.00 in a research report on Monday, May 8th. StockNews.com began coverage on Zoetis in a report on Thursday, May 18th. They set a “buy” rating for the company. Finally, Bank Of America (Bofa) raised their price target on Zoetis from $180.00 to $200.00 and gave the stock a “buy” rating in a report on Tuesday, April 11th. Seven equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $220.50.

Zoetis Price Performance

NYSE ZTS opened at $183.51 on Friday. The company has a 50-day moving average price of $170.43 and a two-hundred day moving average price of $168.81. Zoetis Inc. has a 52 week low of $124.15 and a 52 week high of $187.82. The stock has a market cap of $84.80 billion, a price-to-earnings ratio of 41.42, a price-to-earnings-growth ratio of 2.96 and a beta of 0.77. The company has a current ratio of 3.27, a quick ratio of 1.94 and a debt-to-equity ratio of 1.46.

Zoetis (NYSE:ZTS – Get Free Report) last issued its quarterly earnings data on Thursday, May 4th. The company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $2 billion during the quarter, compared to analyst estimates of $2.02 billion. Zoetis had a return on equity of 50.26% and a net margin of 25.59%. The business’s revenue for the quarter was up .7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.32 EPS. Analysts forecast that Zoetis Inc. will post 5.4 EPS for the current year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 1st. Investors of record on Friday, July 21st will be paid a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date is Thursday, July 20th. Zoetis’s dividend payout ratio is currently 33.86%.

About Zoetis

(Free Report)

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.